Andaluz-Ojeda et al. investigated the ability of MR-proADM to predict the likelihood of death in sepsis patients with different degrees of organ failure, compared to PCT, CRP, and lactate, within the first 12 h of admission. The gene discussed is CRP; the disease is Sepsis.